HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969,435 | +27.1% | 10,822 | +20.8% | 0.00% | +33.3% |
| Q2 2023 | $762,599 | +418.8% | 8,957 | +298.1% | 0.00% | +200.0% |
| Q2 2022 | $147,000 | -0.7% | 2,250 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $148,000 | +59.1% | 2,335 | +33.4% | 0.00% | 0.0% |
| Q4 2021 | $93,000 | -38.8% | 1,750 | -18.8% | 0.00% | 0.0% |
| Q3 2021 | $152,000 | +10.9% | 2,155 | +5.1% | 0.00% | 0.0% |
| Q2 2021 | $137,000 | -38.6% | 2,050 | +2.0% | 0.00% | -50.0% |
| Q1 2021 | $223,000 | +1293.8% | 2,010 | +1388.9% | 0.00% | – |
| Q4 2020 | $16,000 | +33.3% | 135 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | +500.0% | 135 | +440.0% | 0.00% | – |
| Q2 2020 | $2,000 | -33.3% | 25 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |